For the Culture By The Culture. ISSN: 3064-9331.
Cannabis legalization was sold as the end of the illicit market. Instead, stacked taxes, licensing limits, and local bans created price gaps that allowed underground sales to survive. From California’s cultivation tax to Illinois pricing and Michigan’s price compression, this installment of Cannabis Lie examines how policy design, not the plant, determines who wins and who stays in the shadows.
Louisiana HB 373 would create a tightly controlled adult-use cannabis pilot overseen by the Louisiana Department of Health. The bill limits participation to existing medical marijuana dispensaries, imposes permit renewal fees and a 3.5 percent wholesale assessment, and sunsets July 1, 2030, forcing lawmakers to decide whether to make legalization permanent.
Nevada’s legal cannabis market runs in plain sight, yet unlicensed sales keep pace because the rules still leave openings. Price gaps, compliance costs, patchy access, and limited places to consume make the illicit channel feel easier for many buyers. This feature tracks what the numbers show, why raids only disrupt, and what actually shrinks underground sales.
This week’s Reefer Report Card tracks a familiar pattern in cannabis policy: delay dressed as progress. Federal lawmakers punted again on hemp regulation, states flirted with dismantling legal markets, and patients were left waiting. Oversight weakened, accountability faded, and reform stalled. Another week in weed, graded.
A proposed federal hemp framework is being sold as long overdue clarity for a chaotic market. But beneath the promise of order, the structure reveals rigid caps, unresolved enforcement questions, and a quiet shift of power away from states and smaller producers. We break down what the proposal does, what it avoids, and why the difference matters.
Actor David Krumholtz’s experience with Cannabinoid Hyperemesis Syndrome sparked a backlash that reveals a deeper problem in cannabis culture. This piece examines how rare conditions get weaponized, why defensive reactions backfire, and how patients, veterans, and families are erased when nuance collapses on both sides of the cannabis debate.
